David El‐Qutob

409 total citations
30 papers, 262 citations indexed

About

David El‐Qutob is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, David El‐Qutob has authored 30 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology and Allergy, 14 papers in Physiology and 9 papers in Dermatology. Recurrent topics in David El‐Qutob's work include Allergic Rhinitis and Sensitization (14 papers), Asthma and respiratory diseases (14 papers) and Food Allergy and Anaphylaxis Research (11 papers). David El‐Qutob is often cited by papers focused on Allergic Rhinitis and Sensitization (14 papers), Asthma and respiratory diseases (14 papers) and Food Allergy and Anaphylaxis Research (11 papers). David El‐Qutob collaborates with scholars based in Spain, Portugal and United States. David El‐Qutob's co-authors include Enrique Fernández‐Caldas, Adrián Peláez, I. Febrer, Antonio Martorell, José Luis Subiza, C. Garcı́a, Francisco Javier Carrera‐Hueso, Víctor Matheu, Francisco Moreno and Francisco Martínez‐Martínez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Allergy Asthma & Immunology and Clinical Reviews in Allergy & Immunology.

In The Last Decade

David El‐Qutob

30 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David El‐Qutob Spain 8 149 85 60 36 34 30 262
Montserrat Álvaro‐Lozano Spain 12 294 2.0× 165 1.9× 86 1.4× 82 2.3× 43 1.3× 28 430
Mohammad Hassan Bemanian Iran 11 191 1.3× 167 2.0× 69 1.1× 49 1.4× 25 0.7× 47 395
Thanai Pongdee United States 11 171 1.1× 126 1.5× 71 1.2× 52 1.4× 104 3.1× 49 387
Sheena Gupta United States 9 189 1.3× 139 1.6× 44 0.7× 29 0.8× 13 0.4× 19 435
Wirach Chitsuthipakorn Thailand 11 182 1.2× 149 1.8× 45 0.8× 102 2.8× 8 0.2× 32 317
Dong Ho Nahm South Korea 11 106 0.7× 88 1.0× 85 1.4× 39 1.1× 55 1.6× 23 401
M Mairesse Belgium 11 102 0.7× 75 0.9× 48 0.8× 31 0.9× 11 0.3× 36 409
Krzysztof Specjalski Poland 9 54 0.4× 106 1.2× 29 0.5× 30 0.8× 15 0.4× 32 339
Anju Tripathi United States 12 316 2.1× 325 3.8× 69 1.1× 154 4.3× 75 2.2× 18 687
Morteza Fallahpour Iran 12 126 0.8× 180 2.1× 33 0.6× 67 1.9× 15 0.4× 59 440

Countries citing papers authored by David El‐Qutob

Since Specialization
Citations

This map shows the geographic impact of David El‐Qutob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David El‐Qutob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David El‐Qutob more than expected).

Fields of papers citing papers by David El‐Qutob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David El‐Qutob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David El‐Qutob. The network helps show where David El‐Qutob may publish in the future.

Co-authorship network of co-authors of David El‐Qutob

This figure shows the co-authorship network connecting the top 25 collaborators of David El‐Qutob. A scholar is included among the top collaborators of David El‐Qutob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David El‐Qutob. David El‐Qutob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Qutob, David, et al.. (2023). TSLP and asthma: fellow travelers. 4–10. 1 indexed citations
2.
El‐Qutob, David, et al.. (2022). High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis. Heart & Lung. 53. 77–82. 4 indexed citations
3.
El‐Qutob, David, et al.. (2021). Cancer: Still a contraindication for allergen immunotherapy?. World Allergy Organization Journal. 14(10). 100597–100597. 3 indexed citations
4.
Carrera‐Hueso, Francisco Javier, et al.. (2021). Hospitalization budget impact during the COVID-19 pandemic in Spain. Health Economics Review. 11(1). 43–43. 18 indexed citations
5.
Carrera‐Hueso, Francisco Javier, et al.. (2021). Características de pacientes con enfermedades inflamatorias inmunomediadas hospitalizados por infección por SARS-CoV-2. Reumatología Clínica. 18(6). 331–337. 2 indexed citations
6.
Carrera‐Hueso, Francisco Javier, et al.. (2021). Descriptive study of a cohort of COVID-19 hospitalized patients in Spain. SHILAP Revista de lepidopterología. 157(1). 76–83. 5 indexed citations
7.
El‐Qutob, David, et al.. (2021). Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?. Vacunas. 23(2). 71–76. 2 indexed citations
8.
González‐Pérez, Ruperto, et al.. (2021). Precision Medicine in Mite Allergic Rhinitis. SHILAP Revista de lepidopterología. 2. 724727–724727. 3 indexed citations
9.
Borràs, Joan, David El‐Qutob, Reina López, & Ernesto Enrique. (2019). Hypothesized Epitope Localization in Hypersensitivity Reactions to Iodinated Contrast Media. Journal of Investigational Allergology and Clinical Immunology. 29(1). 82–83. 3 indexed citations
10.
Fernández‐Caldas, Enrique, et al.. (2017). Mammalian raw materials used to produce allergen extracts. Annals of Allergy Asthma & Immunology. 119(1). 1–8. 6 indexed citations
11.
El‐Qutob, David, Borja Bartolomé, J. Cuesta, et al.. (2017). Identification of a Lipid Transfer Protein as a New Allergen From Morus alba Pollen. Journal of Investigational Allergology and Clinical Immunology. 27(4). 263–265. 5 indexed citations
12.
Borràs, Josep M. & David El‐Qutob. (2016). Experience With Rapid Desensitization to Chemotherapy in a Type B Hospital. Journal of Investigational Allergology and Clinical Immunology. 26(4). 271–273. 4 indexed citations
13.
Torre, Fernando De la, et al.. (2016). Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy. Journal of Asthma and Allergy. Volume 9. 129–133. 4 indexed citations
14.
El‐Qutob, David. (2015). Off-Label Uses of Omalizumab. Clinical Reviews in Allergy & Immunology. 50(1). 84–96. 73 indexed citations
15.
Subiza, José Luis, David El‐Qutob, & Enrique Fernández‐Caldas. (2015). New Developments in Oral Vaccines and Mucosal Adjuvants. Recent Patents on Inflammation & Allergy Drug Discovery. 9(1). 4–15. 9 indexed citations
16.
El‐Qutob, David, Pedro A. Reche, José Luis Subiza, & Enrique Fernández‐Caldas. (2015). Peptide-Based Allergen Specific Immunotherapy for the Treatment of Allergic Disorders. Recent Patents on Inflammation & Allergy Drug Discovery. 9(1). 16–22. 7 indexed citations
17.
El‐Qutob, David, et al.. (2014). Recent Advances in Immunotherapy for Allergic Diseases. Recent Patents on Inflammation & Allergy Drug Discovery. 8(1). 24–35. 9 indexed citations
18.
El‐Qutob, David. (2012). New Methods of Prevention and Treatment of Allergic Diseases. Recent Patents on Inflammation & Allergy Drug Discovery. 6(1). 46–64. 10 indexed citations
19.
Garcı́a, C., et al.. (2007). Sensitization in early age to food allergens in children with atopic dermatitis. Allergologia et Immunopathologia. 35(1). 15–20. 34 indexed citations
20.
El‐Qutob, David, et al.. (2005). Allergic reaction caused by articaine. Allergologia et Immunopathologia. 33(2). 115–116. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026